Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Novasep and Danisco Announce the first Betaine Industrial Production Process from Bioethanol Side-stream

Published: Thursday, December 16, 2010
Last Updated: Thursday, December 16, 2010
Bookmark and Share
Novasep Process and Danisco announces the scale-up of an innovative process for the production of natural betaine. The plant will be the first to exploit a new extraction process using vinasse, a byproduct of sugar-beet-derived bioethanol.

This process will enable Danisco to substantially increase the availability of natural betaine, which is globally used as a technical animal feed ingredient and currently in short supply.
Danisco pioneered the research and application of natural betaine in animal nutrition in the early 1990s and has clearly demonstrated superior value compared to synthetic alternatives. Unlike synthetic betaine, natural betaine acts as an osmolyte, improving intestinal health and reducing the negative impact of heat-stress on animal production. Currently, market demand for natural betaine outweighs production. The betaine from the new plant will be sold by Danisco as Betafin(TM).
As well as increasing the availability of betaine, the new process will allow the betaine-extracted bioethanol vinasses (residues) to be further recycled and sold as crop fertilizer. Until now, it was possible to extract natural betaine only from sugar-beet molasses, a side stream of sugar production. The new process will be increasingly valuable as the increase of the bioethanol production using beets will generate more and more vinasses.
Novasep Process is responsible for the engineering of the new plant and will provide the complete process line which combines Danisco’s proprietary chromatographic technology, known as NS2P, with membrane and evaporation steps. This project is the latest development of the FAST alliance between Novasep and Danisco in the field of betaine extraction and purification, which has already given birth to several betaine production plants.
“I am delighted about this new milestone in our longstanding relationship with Danisco,” said Antoine Baule, president of Novasep Process, the bioprocess division of Novasep. “By playing a key role in this project, Novasep has again demonstrated its leadership in the development or scale-up of innovative processes in the industrial biotech industry, and its ability to collaborate with key customers and engineering partners in the long term through win-win partnerships.”
Juhani Kuusisto, director of operations at Danisco in charge of betaine sourcing added: “I am very happy about our cooperation with Novasep Process. This new project demonstrates Danisco’s ability to adjust to new market developments and to adapt its NS2P process to new feedstock. This process will substantially increase natural betaine availability on the market place.”
Danisco and Novasep will provide technological support for the betaine production plant with De Smet Engineering and Contractors, being in charge of building construction, erection services and auxiliaries supply of the new development. Tereos, a world player in sugar, starch and bioethanol production, will supply the vinasses and operate the plant at its facility in Origny, France.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Novasep Strengthens its Advisory Board
Professors Alois Fürstner and Alois Jungbauer, renowned experts in catalysis and purification processes, will help boost innovation at Novasep
Tuesday, September 29, 2015
Novasep Invests €10M to Reinforce its Bioconjugation Services
Expansion marks the company’s readiness for full range Antibody Drug Conjugates CMO services.
Thursday, June 25, 2015
Novasep Further Strengthens Management Team
Pierre-Louis Mikus joins as chief legal officer and Bertrand Waymel is promoted to group human resources director.
Wednesday, May 06, 2015
Novasep and Celladon Execute MYDICAR API Supply Agreement
An innovative, genetically-targeted enzyme replacement therapy based on AAV1/SERCA2a.
Thursday, March 26, 2015
Novasep & Celladon Partner
Novasep has entered into an agreement with Celladon, to commercially biomanufacture Celladon’s Mydicar API.
Tuesday, February 24, 2015
Novasep Enters into an Agreement with Celladon
Company selected to commercially biomanufacture Celladon's Mydicar API.
Thursday, February 19, 2015
Novasep Opens New Office in Thailand
Novasep’s extended presence in South East Asia strengthens the company’s ability to address growing needs in the region’s food and feed markets.
Saturday, December 27, 2014
Novasep to Sell its Bahamian Plant to Local Investor
Company has completed the sale of the Bahamian facility and related business of its fully-owned subsidiary, Pharmachem.
Thursday, October 09, 2014
Novasep Passes FDA Inspections on Two Sites
Novasep wins approval to produce new molecular entity for US market.
Thursday, July 24, 2014
Novasep’s €4 M ADC Manufacturing Plant Extension Commissioned
The new Highly Potent API manufacturing capacity at the Le Mans facility will boost Novasep’s ability to meet customer demand for producing anti-cancer therapies.
Friday, May 16, 2014
Novasep Reports Full Year 2013 Results
Results show strong growth and beating guidance.
Friday, March 28, 2014
Novasep Appoints CEO Michel Spagnol as Chairman
Novasep presents strategic developments.
Wednesday, March 05, 2014
Novasep Expands and Opens Subsidiary in India
Subsidiary to meet India’s increasing need for high efficacy processes for its fast growing food and feed industries.
Friday, February 14, 2014
Novasep Attracts Top Talent to Complete its Executive Team
Thierry Van Nieuwenhove, a seasoned CMO top executive, joins Novasep as president of the Synthesis Business Unit.
Monday, January 20, 2014
Novasep Expands and Opens Subsidiary in India
Novasep Process Engineering Services PVT LTD will meet India’s increasing need for high efficacy processes for its fast growing food and feed industries.
Monday, December 16, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos